Study compares heparin to warfarin for treatment of blood clots in patients with cancer. ScienceDaily. Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2015 / 08 / 150818112727.htm.

Among patients with active cancer and acute symptomatic venous thromboembolism (VTE; blood clots in the deep veins), the use of the low molecular-weight heparin tinzaparin daily for 6 months ...

The warfarin group had far fewer complications than the group that was bridged with low-molecular-weight heparin. The warfarin group had a pocket hematoma rate of 3.5% compared with 16% in ...

In an anticoagulation practice, I occasionally see patients discharged on low-molecular-weight heparin (LMWH) along with warfarin after cerebral vascular accident (CVA). Whether the CVA was ...

ORLANDO, Fla. — “Interestingly, clotting events only occurred in patients on heparin-free hemodialysis and warfarin,” said Graham Abra, MD, here at the Annual Dialysis Conference.

Warfarin exists as two isomers, the warfarin-S and the warfarin-R forms. ... After initial treatment of VTE with unfractionated heparin or a low–molecular-weight heparin, ...

The common practice of administering heparin soon after cardioembolic stroke is associated with an increased risk for serious bleeding, according to an article in the Archives of Neurology.

According to a new study published in JAMA, treatment with low molecular-weight heparin tinzaparin did not significantly reduce recurrent venous thromboembolism (VTE) or major bleeding and overall ...

Following transradial coronary angiography, radial artery occlusion is more likely to occur in patients on chronic warfarin therapy but no parenteral anticoagulation compared with those receiving ...

Panel B shows a scenario for patients with heparin-induced thrombocytopenia (HIT) who receive heparin during cardiac surgery with routine heparin–warfarin overlap (e.g., mechanical valve ...

Warfarin is very inexpensive, less than $5/month, ... Heparin (including low molecular weight heparin) is almost never used for long-term treatment of AFib except during pregnancy.